MTOR and rheumatoid arthritis: In a multi-center study involving 121 RA patients, it was found that there was a greater response to the therapy in the group of patients treated with the mTOR inhibitor everolimus plus MTX than the MTX alone, suggesting that autophagy modulators may be added to standard therapy to increase the effectiveness of the therapy (96).